Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Glucarpidase
Therapeutic Area : Oncology
Study Phase : Phase I
Recipient : Assistance Publique – Hôpitaux de Paris
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Glucarpidase is a Enzyme drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Central Nervous System Lymphoma.
Product Name : Undisclosed
Product Type : Enzyme
Upfront Cash : Inapplicable
November 26, 2021
Lead Product(s) : Glucarpidase
Therapeutic Area : Oncology
Highest Development Status : Phase I
Recipient : Assistance Publique – Hôpitaux de Paris
Deal Size : Inapplicable
Deal Type : Inapplicable